Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
14,348,669
-
Share change
-
+2,230,498
-
Total reported value
-
$463,905,724
-
Price per share
-
$32.33
-
Number of holders
-
67
-
Value change
-
+$65,475,499
-
Number of buys
-
43
-
Number of sells
-
28
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q4 2015
As of 31 Dec 2015,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,348,669 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, Partner Fund Management, L.P., JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Foresite Capital Management III, LLC, RA CAPITAL MANAGEMENT, LLC, and BAKER BROS. ADVISORS LP.
This page lists
67
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.